PENBUTOLOL AND CARTEOLOL - 2 NEW BETA-ADRENERGIC BLOCKERS WITH PARTIAL AGONISM

被引：13

作者：

FRISHMAN, WH ^{[1
]}

COVEY, S ^{[1
]}

机构：

[1] BETH ISRAEL MED CTR,DEPT MED,NEW YORK,NY 10003

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1990年 / 30卷 / 05期

关键词：

D O I：

10.1002/j.1552-4604.1990.tb03479.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Penbutolol and carteolol are two new long acting, nonselective beta‐adrenergic blockers which have been approved for the treatment of systemic hypertension. Both drugs have intrinsic sympathomimetic activity (partial agonist activity), however, less than that seen with pindolol. They appear to cause less resting bradycardia than propranolol, have no effect on lipids and lipoproteins, and have favorable side effect profiles. 1990 American College of Clinical Pharmacology

引用

页码：412 / 421

页数：10

共 54 条

[31] MURAI A, 1987, Japanese Journal of Geriatrics, V24, P35
[32] INTRINSIC SYMPATHOMIMETIC ACTIVITY OF PENBUTOLOL
NYBERG, G
WILHELMSSON, C
VEDIN, A
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (06) : 381 - 386
[33] PENBUTOLOL (HOE 893D) IN PRIMARY HYPERTENSION - BLOOD-PRESSURE EFFECTS, TOLERANCE AND PLASMA-CONCENTRATIONS
OHMAN, KP
ASPLUND, J
LANDAHL, S
LIANDER, B
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (02) : 95 - 99
[34] REED, 1988, LEVATOL PENBUTOLOL S
[35] RINGHAM GL, 1987, J CLIN PHARMACOL, V27, P715
[36] CARTEOLOL, AN ANTIHYPERTENSIVE BETA-BLOCKER WITH INTRINSIC SYMPATHOMIMETIC ACTIVITY, REDUCES ECG EVIDENCE OF LEFT-VENTRICULAR HYPERTROPHY
ROSALES, OR
SANDER, GE
ROFFIDAL, L
GIVEN, MB
GILES, TD
[J]. CHEST, 1989, 95 (01) : 43 - 47
[37] SABOROWSKI F, 1983, ARZNEIMITTEL-FORSCH, V33-1, P310
[38] USEFULNESS OF PENBUTOLOL FOR SYSTEMIC HYPERTENSION
SCHOENBERGER, JA
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (18) : 1339 - 1342
[39] SENNELLO L T, 1987, Advances in Therapy, V4, P298
[40] SHIVDE JV, 1977, CURR THER RES CLIN E, V22, P501

← 1 2 3 4 5 6 →